Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 nov. 2016 08h00 HE | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference

BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
21 nov. 2016 08h00 HE | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Two Presentations Demonstrating the Potential for CRISPR Gene Editing To Treat Sickle Cell Disease and β-Thalassemia

BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 21, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...
08 nov. 2016 08h00 HE | Source: CRISPR Therapeutics AG

CRISPR Therapeutics to Present at the Stifel 2016 Healthcare Conference

BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
18 oct. 2016 21h59 HE | Source: CRISPR Therapeutics AG

CRISPR Therapeutics Announces Pricing of Initial Public Offering

BASEL, Switzerland and CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing...